Sprouty4 levels are increased under hypoxic conditions by enhanced mRNA stability and transcription

Biological Chemistry

Volumn 391, Issue 7, 2010, Pages 813-821

  Haigl, Barbara ^a   Mayer, Christoph Erik ^a,b   Siegwart, Gerald ^a   Sutterlüty, Hedwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

desferrioxamine (DFO); extracellular signalling regulated kinase (ERK); hypoxia; Sprouty

Indexed keywords

DEFEROXAMINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SPROUTY PROTEIN; SPROUTY4 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYPOXIA; IRON CHELATION; IRON DEPLETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; RNA TRANSCRIPTION;

ANOXIA; CELL HYPOXIA; CELLS, CULTURED; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; TRANSCRIPTION, GENETIC;

EID: 77954594813     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2010.082     Document Type: Article

References (50)

1. Ayada, T., Taniguchi, K., Okamoto, E, Kato, R., Komune, S., Takae-su, G., and Yoshimura, A. (2009). Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis. Oncogene 28, 1076-1088.
2. Basson, M.A., Akbulut, S., Watson-Johnson, J., Simon, R., Carroll, T.J., Shakya, R., Gross, I., Martin, G.R., Lufkin, T., McMahon, A.P., et al. (2005). Sproutyl is a critical regulator of GDNE/ RET-mediated kidney induction. Dev. Cell 8, 229-239.
3. Basson, M.A., Watson-Johnson, J., Shakya, R., Akbulut, S., Hyink, D. , Costantini, E.D., Wilson, P.D., Mason, I.J., and Licht, J.D. (2006). Branching morphogenesis of the ureteric epithelium during kidney development is coordinated by the opposing functions of GDNE and Sproutyl. Dev. Biol. 299, 466-477.
4. Berger, W., Hauptmann, E., Elbling, L., Vetterlein, M., Kokoschka, E. M., and Micksche, M. (1997). Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int. J. Cancer 71, 108-115. (Pubitemid 27158417)
5. Cabrita, M.A. and Christofori, G. (2008). Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 11, 53-62.
6. Chambers, D. and Mason, I. (2000). Expression of sprouty2 during early development of the chick embryo is coincident with known sites of EGE signalling. Mech. Dev. 91, 361-364.
7. Chi, L., Itaranta, P., Zhang, S., and Vainio, S. (2006). Sprouty2 is involved in male sex organogenesis by controlling fibroblast growth factor 9-induced mesonephric cell migration to the developing testis. Endocrinology 147, 3777-3788.
8. de Maximy, A.A., Nakatake, Y., Moncada, S., Itoh, N., Thiery, J.P., and Bellusci, S. (1999). Cloning and expression pattern of a mouse homologue of Drosophila sprouty in the mouse embryo. Mech. Dev. 81, 213-216.
9. Ding, W. and Warburton, D. (2008). Down-regulation of Sprouty2 via p38 MAPK plays a key role in the induction of cellular apoptosis by tumor necrosis factor a. Biochem. Biophys. Res. Commun. 575, 460-464.
10. Ding, W., Bellusci, S., Shi, W., and Warburton, D. (2004). Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L52-L59
11. Edwin, E. and Patel, T.B. (2008). A novel role of Sprouty 2 in regulating cellular apoptosis. J. Biol. Chem. 285, 3181-3190.
12. Eong, C.W., Chua, M.-S., McKie, A.B., Ling, S.H.M., Mason, V., Li, R., Yusoff, P., Lo, T.L., Leung, H.Y., So, S.K.S., et al. (2006). Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res. 66, 2048-2058.
13. Eraisl, P., Mazzone, M., Schmidt, T., and Carmeliet, P. (2009). Regulation of angiogenesis by oxygen and metabolism. Dev. Cell. 16, 167-179.
14. Erank, M.J., Dawson, D.W., Bensinger, S.J., Hong, J.S., Knosp, W.M., Xu, L., Balatoni, C.E., Allen, E.L., Shen, R.R., Bar-Sagi, D., et al. (2009). Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Blood 115, 2478-2487.
15. Eu, D. and Richardson, D.R. (2007). Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/ WAE1 by iron depletion. Blood 110, 752-761.
16. Gross, I., Bassit, B., Benezra, M., and Licht, J.D. (2001). Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J. Biol. Chem. 276, 46460-46468.
17. Gross, I., Armant, O., Benosman, S., de Aguilar, J.L., Ereund, J.N., Kedinger, M., Licht, J.D., Gaiddon, C., and Loeffler, J.P. (2007). Sprouty2 inhibits BDNE-induced signaling and modulates neu-ronal differentiation and survival. Cell Death Diff. 14, 18021812.
18. Hacohen, N., Kramer, S., Sutherland, D., Hiromi, Y., and Krasnow, M.A. (1998). Sprouty encodes a novel antagonist of EGE signaling that patterns apical branching of the Drosophila airways. Cell 92, 253-263.
19. Horowitz, A. and Simons, M. (2008). Branching morphogenesis. Circ. Res. 105, 784-795.
20. Hua, Z., Lv, Q., Ye, W., Wong, C.-K.A., Cai, G., Gu, D., Ji, Y., Zhao, C., Wang, J., Yang, B.B., et al. (2006). MiRNA-directed regulation of VEGE and other angiogenic factors under hypoxia. PLoS One 1, e116.
21. Impagnatiello, M.A., Weitzer, S., Gannon, G., Compagni, A., Cot-ten, M., and Christofori, G. (2001). Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J. Cell Biol. 152, 10871098.
22. Ishida, M., Ichihara, M., Mii, S., Jijiwa, M., Asai, N., Enomoto, A., Kato, T., Majima, A., Ping, J., Murakumo, Y., et al. (2007). Sprouty2 regulates growth and differentiation of human neuro-blastoma cells through RET tyrosine kinase. Cancer Sci. 98, 815-821.
23. Kaelin, W.G. Jr. and Ratcliffe, P.J. (2008). Oxygen sensing by met-azoans: the central role of the HIE hydroxylase pathway. Mol. Cell 50, 393-402.
24. Kim, B.S., Yoon, K.H., Oh, H.M., Choi, E.Y., Kim, S.W., Han, W.C., Kim, E.A., Choi, S.C., Kim, T.H., Yun, K.J., et al. (2002). Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death. Cell. Immunol. 220, 96-106.
25. Klein, O.D., Minowada, G., Peterkova, R., Kangas, A., Yu, B.D., Lesot, H., Peterka, M., Jernvall, J., and Martin, G.R. (2006). Sprouty genes control diastema tooth development via bidirectional antagonism of epithelial- mesenchymal EGE signaling. Dev. Cell 11, 181-190.
26. Kwabi-Addo, B., Wang, J., Erdem, H., Vaid, A., Castro, P., Ayala, G., and Ittmann, M. (2004). The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res. 64, 4728-4735.
27. Lee, C.C., Putnam, A.J., Miranti, C.K., Gustafson, M., Wang, L.M., Vande Woude, G.E., and Gao, C.E. (2004). Overexpression of sprouty 2 inhibits HGE/SE-mediated cell growth, invasion, migration, and cytokinesis. Oncogene 25, 5193-5202.
28. Levy, A.P. (1998). Hypoxic regulation of VEGE mRNA stability by RNA-binding proteins. Trends Cardiovasc. Med. 8, 246-250.
29. Lito, P., Mets, B.D., Appledorn, D.M., Maher, V.M., and McCor-mick, J.J. (2009). Sprouty 2 regulates DNA damage-induced apoptosis in Ras-transformed human fibroblasts. J. Biol. Chem. 284, 848-854.
30. Lo, T.L., Yusoff, P., Eong, C.W., Guo, K., McCaw, B.J., Phillips, W.A., Yang, H., Wong, E.S.M., Leong, H.E., Zeng, Q., et al. (2004). The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res. 64, 6127-6136.
31. Mason, J.M., Morrison, D.J., Basson, M.A., and Licht, J.D. (2006). Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16, 45-54.
32. Meister, G. (2007). miRNAs get an early start on translational silencing. Cell 151, 25-28.
33. Nadeau, R.J., Toher, J.L., Yang, X., Kovalenko, D., and Eriesel, R. (2007). Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2. J. Cell Biochem. 100, 151-160.
34. Nakayama, K., Erew, I.J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Erappell, P.B., et al. (2004). Siah2 regulates stability of prolyl-hydroxylases, controls HIE1 a abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952.
35. Ozaki, K., Kadomoto, R., Asato, K., Tanimura, S., Itoh, N., and Kohno, M. (2001). ERK pathway positively regulates the expression of Sprouty genes. Biochem. Biophys. Res. Commun. 285, 1084-1088.
36. Pioli, P.A. and Rigby, W.E. (2001). The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression. J. Biol. Chem. 276, 40346-40352.
37. Poppleton, H.M., Edwin, E., Jaggar, L., Ray, R., Johnson, L.R., and Patel, T.B. (2004). Sprouty regulates cell migration by inhibiting the activation of Rac1 GTPase. Biochem. Biophys. Res. Commun. 525, 98-103.
38. Sasaki, A., Taketomi, T., Wakioka, T., Kato, R., and Yoshimura, A. (2001). Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J. Biol. Chem. 276, 36804-36808.
39. Sasaki, A., Taketomi, T., Kato, R., Saeki, K., Nonami, A., Sasaki, M., Kuriyama, M., Saito, N., Shibuya, M., and Yoshimura, A. (2003). Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat. Cell Biol. 5, 427-432. (Pubitemid 36592265)
40. Shih, S.C. and Claffey, K.P. (1999). Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J. Biol. Chem. 274, 1359-1365.
41. Shim, K., Minowada, G., Coling, D.E., and Martin, G.R. (2005). Sprouty2, a mouse deafness gene, regulates cell fate decisions in the auditory sensory epithelium by antagonizing EGE signaling. Dev. Cell. 8, 553-564.
42. Sutterluty, H., Mayer, C.-E., Setinek, U., Attems, J., Ovtcharov, S., Mikula, M., Mikulits, W., Micksche, M., and Berger, W. (2007). Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Mol. Cancer Res. 5, 509-520.
43. Taketomi, T., Yoshiga, D., Taniguchi, K., Kobayashi, T., Nonami, A., Kato, R., Sasaki, M., Sasaki, A., Ishibashi, H., Moriyama, M., et al. (2005). Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia. Nat. Neurosci. 8, 855-857.
44. Taniguchi, K., Ayada, T., Ichiyama, K., Kohno, R.-i., Yonemitsu, Y., Minami, Y., Kikuchi, A., Maehara, Y., and Yoshimura, A. (2007). Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of EGE signaling. Biochem. Biophys. Res. Commun. 552, 896-902.
45. Taniguchi, K., Ishizaki, T., Ayada, T., Sugiyama, Y., Wakabayashi, Y., Sekiya, T., Nakagawa, R., and Yoshimura, A. (2009a). Sprou-ty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. Cancer Sci. 100, 1648-1654.
46. Taniguchi, K., Sasaki, K., Watari, K., Yasukawa, H., Imaizumi, T., Ayada, T., Okamoto, E., Ishizaki, T., Kato, R., Kohno, R., et al. (2009b). Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. PLoS One 4, e5467.
47. Templeton, D.M. and Liu, Y. (2003). Genetic regulation of cell function in response to iron overload or chelation. Biochim. Biophys. Acta 1619, 113-124.
48. Tsumura, Y., Toshima, J., Leeksma, O.C., Ohashi, K., and Mizuno, K. (2005). Sprouty-4 negatively regulates cell spreading by inhibiting the kinase activity of testicular protein kinase. Bio-chem. J. 587, 627-637.
49. Yigzaw, Y., Cartin, L., Pierre, S., Scholich, K., and Patel, T.B. (2001). The C terminus of sprouty is important for modulation of cellular migration and proliferation. J. Biol. Chem. 276, 22742-22747.
50. Zhang, C., Chaturvedi, D., Jaggar, L., Magnuson, D., Lee, J.M., and Patel, T.B. (2005). Regulation of vascular smooth muscle cell proliferation and migration by human sprouty 2. Arterioscler. Thromb. Vasc. Biol. 25, 533-538.